ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
44 hedge funds and large institutions have $2.75M invested in Zynerba Pharmaceuticals, Inc in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
44
Holding in Top 10
–
Calls
$10K
Puts
–
Top Buyers
| 1 | +$38.1K | |
| 2 | +$14K | |
| 3 | +$8K | |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$6.11K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.91K |
Top Sellers
| 1 | -$339K | |
| 2 | -$116K | |
| 3 | -$103K | |
| 4 |
IEFM
IQ EQ Fund Management
Dublin 2,
Ireland
|
-$65.1K |
| 5 |
Millennium Management
New York
|
-$44.6K |